Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
Clinical trial NCT02862600 · TERMINATED
Trial details
- NCT number
- NCT02862600
- Sponsor
- Heart Metabolics Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-04-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.